Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FV7H8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $68,032
Award facts
- Contract value 100% obligated
- $68,032.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $68,032.34 to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Dupixent 300 mg/2 ml pen auto-injectors. This firm fixed price delivery order, with an ultimate completion date of January 6, 2026, represents a single-source procurement with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dupixent is a biologic medication commonly used to treat moderate-to-severe eczema, asthma, and allergic conditions, and this procurement supports federal healthcare requirements, likely for military and veteran medical systems managed through the Defense Health Agency.
This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.999 billion global pharmaceutical support vehicle valued through December 2026. As a major pharmaceutical distributor and critical vendor within the federal medical supply chain, AmerisourceBergen maintains extensive federal contract awards across multiple therapeutic domains. The company's IDC enables flexible procurement of brand-name and generic medications, vaccines, and specialized medical supplies to support military healthcare programs worldwide, positioning it as a key strategic partner for federal pharmaceutical sourcing through competitive award mechanisms.
Quick answers
Who was awarded contract SPE2DR26FV7H8?
SPE2DR26FV7H8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26FV7H8 worth?
The government has obligated $68,032 on SPE2DR26FV7H8.
Is contract SPE2DR26FV7H8 an order under another contract?
Yes. SPE2DR26FV7H8 is a delivery order under SPE2DR25D2214, an indefinite delivery contract.
Was contract SPE2DR26FV7H8 competed?
The extent of competition for SPE2DR26FV7H8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award